Swiss study aims to curb antibiotic overuse with new guidelines

NCT ID NCT07396428

Recruiting now Knowledge-focused Sponsor: Center for Primary Care and Public Health (Unisante), University of Lausanne, Switzerland Source: ClinicalTrials.gov ↗

First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study tests whether implementing new Swiss national guidelines for acute respiratory infections can reduce unnecessary antibiotic prescribing in primary care. Researchers will work with 200 family doctors in quality circles and walk-in clinics, providing training and materials to support targeted use of CRP testing and shared decision-making. The goal is to slow antibiotic resistance by cutting down on antibiotics for viral infections, where they don't work.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance: Training session on acute respiratory infection guideline within a multifaceted implementation strategy
What this could lead to: If successful, this could provide a proven way to reduce unnecessary antibiotic use in primary care, helping to slow antibiotic resistance.
What could go wrong: This is an implementation study, not a drug trial, so it won't directly treat disease. Results depend on doctors voluntarily following guidelines, and success may vary across clinics.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ACUTE RESPIRATORY INFECTION are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

respiratory tract infectious disorder

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

ACUTE RESPIRATORY INFECTION INFLUENZA -LIKE ILLNESS

Contacts and locations

Locations

Unisanté
RECRUITING

Lausanne, Canton of Vaud, 1011, Switzerland

More trials for these conditions

Other studies related to the condition(s) this trial covers.